Send Email
Send SMS
Search


Oncology Drugs

Manufacturer of a wide range of products which include jakavi tablets, enzalutamide capsules, rituximab, bevacizumab, trastuzumab and zytiga tablet.

Jakavi Tablets

REQUEST CALLBACK

Jakavi Tablets
  • Jakavi Tablets
  • Jakavi Tablets
  • Jakavi Tablets
  • Jakavi Tablets
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1 / PieceGet Latest Price

Product Details:
Minimum Order Quantity1 Piece
BrandJAKAVI
Packaging TypeTABLET
Usage/ApplicationAS DIRECTED BY PHYSICIAN
Anti Cancer Medicine TypeTABLET
CompositionRuxolitinib
Drug NameRuxolitinib
Dose/StrengthAS DIRECTED BY PHYSICIAN
Dosage FormSOLID

Product Specification
BrandJAKAVI
Packaging TypeTABLET
Usage/ApplicationAS DIRECTED BY PHYSICIAN
Product TypeTABLET
CompositionRuxolitinib
Drug NameRuxolitinib
SaltRuxolitinib
Dose/StrengthAS DIRECTED BY PHYSICIAN
Dosage FormSOLID
Minimum Order Quantity5 Pack
Product DescriptionJakavi Tablets contains Ruxolitinib which is used to treat a condition known as myelofibrosis. It works by blocking your body from producing substances called growth factors


Additional Information:

  • Delivery Time: 2 weeks
Yes! I am interested

Enzalutamide Capsules

REQUEST CALLBACK

Enzalutamide Capsules
  • Enzalutamide Capsules
  • Enzalutamide Capsules
  • Enzalutamide Capsules
  • Enzalutamide Capsules
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1 / PieceGet Latest Price

Product Details:
Minimum Order Quantity1 Piece
Packaging TypeBottles
Packaging Size120 Capsules
Dose/Strength40 mg
FormCapsules

Product Details:
Brand
Dose/Strength40 mg
Packaging TypeBottles
FormCapsules
Packaging Size120 Capsules
Caution:
  • Swallow capsules whole
  • Do not chew, dissolve, or open the capsules


Additional Information:

  • Delivery Time: 2 weeks
Yes! I am interested

Rituximab

REQUEST CALLBACK

Rituximab
  • Rituximab
  • Rituximab
  • Rituximab
  • Rituximab
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1 / UnitGet Latest Price

Product Details:
Minimum Order Quantity1 Unit
Usage/ApplicationClinical,Hospital
Anti Cancer Medicine TypeAllopathic
Drug NameRituximab
Generic NameRituximab

Product Specification
Packaging TypeVial
UsageClinical, Hospital
Packaging Size50 ml
Medicine TypeAllopathic

Dose500 mg
Product Description

We are the leading exporters of Rituximab 500 mg Injection
 

MabThera consists of the drug Rituximab, belonging to a class of medications termed as antineoplastic agents. The medicine is used for treating adult patients suffering from serving active rheumatoid arthritis. It is also used, either alone or in combination with other drugs for treating non-Hodgkin's lymphoma. It also finds use in the treatment of rheumatoid arthritis.



Additional Information:

  • Delivery Time: 2 weeks
Yes! I am interested

Bevacizumab

REQUEST CALLBACK

Bevacizumab
  • Bevacizumab
  • Bevacizumab
  • Bevacizumab
  • Bevacizumab
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1 / PieceGet Latest Price

Product Details:
Minimum Order Quantity1 Piece
UsageCommercial, Clinical, Hospital, Persona

Product Specification
UsageCommercial, Clinical, Hospital, Personal
Product TypeFinished Product
Form of MedicineInjection
Minimum Order Quantity5 1 box
Product Description

 

Uses of Cizumab Injection

Cizumab 400mg Injection is used in the treatment ofcancer of colon and rectum,breast cancer,non-small cell lung cancer,ovarian cancer, cancer of fallopian tube andkidney cancer. It is also used to treat eye diseases like wet form of age-related macular degeneration and diabetic macular edema.



Additional Information:

  • Delivery Time: 2 weeks
Yes! I am interested

Trastuzumab

REQUEST CALLBACK

Trastuzumab
  • Trastuzumab
  • Trastuzumab
  • Trastuzumab
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1 / PieceGet Latest Price

Product Details:
Minimum Order Quantity1 Piece
Usage/ApplicationClinical,Hospital,Personal,Commercia
CompositionTrastuzumab for Injection

Product Specification
Dose440 mg
Packaging TypeBox
Packaging SizeSingle Dose Vial


CompositionTrastuzumab for Injection
UsageClinical, Hospital, Personal,Commercial
Product DescriptionIndications:

Breast cancer

Metastatic breast cancer

CANMab is indicated for the treatment of adult patients with HER2 positive metastatic breast cancer: (MBC):
  • As monotherapy for the treatment of those patients who have received at least two chemotherapy regimens for their metastatic disease. Prior chemotherapy must have included at least an anthracycline and a taxane unless patients are unsuitable for these treatments. Hormone receptor positive patients must also have failed hormonal therapy, unless patients are unsuitable for these treatments.
  • In combination with paclitaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease and for whom an anthracycline is not suitable.
  • In combination with docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease.
  • In combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive MBC, not previously treated with trastuzumab.

Early breast cancer
  • CANMab is indicated for the treatment of adult patients with HER2 positive early breast cancer. (EBC).
  • Following surgery, chemotherapy (neoadjuvant or adjuvant) and radiotherapy (if applicable).
  • Following adjuvant chemotherapy with doxorubicin and cyclophosphamide, in combination with paclitaxel or docetaxel.
  • In combination with adjuvant chemotherapy consisting of docetaxel and carboplatin.
  • In combination with neoadjuvant chemotherapy followed by adjuvant CANMab therapy, for locally advanced (including inflammatory) disease or tumours > 2 cm in diameter.
  • CANMab should only be used in patients with metastatic or early breast cancer whose tumours have either HER2 overexpression or HER2 gene amplification as determined by an accurate and validated assay.

Metastatic gastric cancer
  • CANMab in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of adult patients with HER2 positive metastatic adenocarcinoma of the stomach or gastro-esophageal junction who have not received prior anti-cancer treatment for their metastatic disease.
  • CANMab should only be used in patients with metastatic gastric cancer (MGC) whose tumours have HER2 overexpression as defined by IHC2+ and a confirmatory SISH or FISH result, or by an IHC 3+ result.


Additional Information:

  • Delivery Time: 2 weeks
Yes! I am interested

Zytiga Tablet

REQUEST CALLBACK

Zytiga Tablet
  • Zytiga Tablet
  • Zytiga Tablet
  • Zytiga Tablet
  • Zytiga Tablet
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1 / PieceGet Latest Price

Product Details:
Minimum Order Quantity1 Piece
Packaging Typebottle
Usage/ApplicationClinical, Hospital
Packaging Size120's

Product Specification
UsageClinical, Hospital
Packaging Size120's
Packaging Typebottle
Dose/Strength (ex. 1 mg or 1 ml)250mg
Minimum Order Quantity2 Bottle
Product Description

we are involved in offering best quality of Zytiga. This Zytiga is offered by us to customers in bulk at reasonable rates and these products are highly appreciated for their effective usage. The offered Zytiga is extensively used to treat men with metastatic castration-resistant prostate cancer. Further, we provide these products to customers in safe and perfect packaging.

 

Features:

 

  • Perfectly formulated
  • Hygienically packed
  • Accurate composition
Yes! I am interested

Palbociclib Capsules

REQUEST CALLBACK

Palbociclib Capsules
  • Palbociclib Capsules
  • Palbociclib Capsules
  • Palbociclib Capsules
  • +1 Palbociclib Capsules
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1 / PieceGet Latest Price

Product Details:
Minimum Order Quantity1 Piece
Usage/ApplicationCommerical
TypeAllopathic
Packaging TypeCapsules

Product Specification
Packaging TypeCapsules
Packaging Size21 Capsules per Bottle
Medicine TypeAllopathic
UsageCommerical
Strength125mg
Product DescriptionWHAT IS PALBACE ?
Palbace is a targeted therapy. This medication is classified as a “cyclin-dependent kinase (CDK) 4/6 inhibitor”. It works by stopping the growth of cancer cells.

Medicine Uses:
Palbociclib is used for treating certain kinds of breast cancer in women past menopause. 

Palbociclib Common Side Effects:
Decreased appetite; diarrhea; hair thinning or loss; mouth irritation or mouth sores; nausea; nose or throat irritation; tiredness; vomiting; weakness.
Seek medical attention right away if any of these SEVERE side effects occur:Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); burning, numbness, or tingling; dizziness; symptoms of bleeding (eg, vomiting blood or vomit that looks like coffee grounds; coughing up blood; blood in the urine; black, red, or tarry stools; bleeding from the gums; nosebleeds; unusual vaginal bleeding; bruises without a reason or that get bigger; any bleeding that is severe or that you cannot stop); symptoms of infection (eg, fever, chills, sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, painful urination, mouth sores, wound that will not heal, itching or pain); unusual tiredness or weakness.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

Safety Information:
Tell your doctor or dentist that you take Palbace before you receive any medical or dental care, emergency care, or surgery.
Yes! I am interested

Pegfilgrastim Injection

REQUEST CALLBACK

Pegfilgrastim Injection
  • Pegfilgrastim Injection
  • Pegfilgrastim Injection
  • Pegfilgrastim Injection
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1 / PieceGet Latest Price

Product Details:
Minimum Order Quantity1 Piece
Usage/ApplicationCommercial,Clinical,Hospital,Personal
Dose Strength6mg/ 0,6m/s.c

Product Specification
UsageCommercial, Clinical, Hospital, Personal
Dose6mg/ 0,6m/s.c
Minimum Order Quantity3 Pack
Product Description

Indication:

Pegfilgrastim is used to reduce the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils (a type of blood cell needed to fight infection). Pegfilgrastim is also used to increase the chance of survival in people who have been exposed to harmful amounts of radiation, which can cause severe and life-threatening damage to bone marrow. Pegfilgrastim is in a class of medications called colony stimulating factors. It works by helping the body make more neutrophils.

Dosage Administration:

Pegfilgrastim comes as a solution (liquid) in prefilled injection syringes and in a pre-filled automatic injection device (On-body Injector) to inject subcutaneously (under the skin). If you are using pegfilgrastim to decrease the risk of infection during chemotherapy, it is usually given as a single dose for each chemotherapy cycle, no sooner than 24 hours after the last dose of chemotherapy of the cycle is given and more than 14 days before beginning the next chemotherapy cycle. If you are using pegfilgrastim because you have been exposed to harmful amounts of radiation, it is usually given as 2 single doses, one week apart. Your doctor will tell you exactly when you should use pegfilgrastim.

Pegfilgrastim may be given to you by a nurse or other healthcare provider, or you may be told to inject the medication at home. If you will be injecting pegfilgrastim at home, follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Use pegfilgrastim exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.

If you will be injecting pegfilgrastim yourself, a healthcare provider will show you how to inject the medication. Be sure that you understand these directions. Ask your healthcare provider if you have any questions about where on your body you should inject pegfilgrastim, how to give the injection, or how to dispose of used needles and syringes after you inject the medication.

If your pegfilgrastim comes in a pre-filled automatic injection device (On-body Injector), the device will usually be applied to your abdomen or the back of your arm by a nurse or other healthcare provider the day before you will receive the dose of pegfilgrastim. The next day (approximately 27 hours after the On-Body Injector was applied to your skin), the dose of pegfilgrastim will be automatically injected over 45 minutes.

 



Additional Information:

  • Delivery Time: 2 weeks
Yes! I am interested

Tecentriq Atezolizumab

REQUEST CALLBACK

Tecentriq Atezolizumab
  • Tecentriq Atezolizumab
  • Tecentriq Atezolizumab
  • Tecentriq Atezolizumab
  • Tecentriq Atezolizumab
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1 / PieceGet Latest Price

Product Details:
Minimum Order Quantity1 Piece
Dose/Strength1200

Product Specification
Dose/Strength1200
Dose1200
Packaging Typevial
BrandTocentriq
Product Description

TECENTRIQ® (atezolizumab) Advanced Urothelial Carcinoma (mUC) or metastatic non-small cell lung cancer (NSCLC) treatment.
1200mg



Additional Information:

  • Delivery Time: 2 weeks
Yes! I am interested

Darzalex Daratumumab

REQUEST CALLBACK

Darzalex Daratumumab
  • Darzalex Daratumumab
  • Darzalex Daratumumab
  • Darzalex Daratumumab
Get Best Quote

Thanks for Contacting Us.

Approx. Rs 1 / PieceGet Latest Price

Product Details:
Minimum Order Quantity1 Piece
Packaging Typeglass bottle

Product Specification
Packaging Size5 ml
Packaging TypeGlass Bottle
Dose/Strength (ex. 1 mg or 1 ml)100 mg
Medicine TypeAllopathic
Minimum Order Quantity10 Pack
Product DescriptionDarzalex™, also known as daratumumab, is the first monoclonal antibody approved for use in multiple myeloma.


Additional Information:

  • Delivery Time: 2 weeks
Yes! I am interested

 
X


Explore More Products

Contact via E-mail
Contact via SMS
Inorbvict Healthcare India Private Limited
Rajesh Kumar (Director)
Shop No. 2, A Wing, Prestone Wood , Pimple Nilakh,
Pune - 411027, Maharashtra, India
Call Us: 
Call Response Rate: 64%
Share Us :
F G T L



Home  |   About Us   |  Our Products  |  Site Map  |   Contact Us

© Inorbvict Healthcare India Private Limited. All Rights Reserved (Terms of Use)
Developed and Managed by IndiaMART InterMESH Limited

Inorbvict Healthcare India Private Limited